Study on systemic sclerosis in western Sweden
Part of Lungs & breathing, Skin clinical trials.
This study is looking at people with systemic sclerosis (a condition that causes hardening and tightening of the skin and can affect internal organs) to learn more about the disease. You may join if you have been diagnosed with this condition and meet a few other requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with systemic sclerosis (SSc) by a doctor according to standard guidelines.
- You do not have mixed connective tissue disease (MCTD).
- You can speak and read Swedish.
- You do not have severe cognitive impairment that would make participation difficult.
- Your blood counts are within a safe range (your doctor can check this).
- You do not have an allergy to local anesthetic if you agree to a skin biopsy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a detailed look at your skin and scalp (often with a magnifying exam) to learn more about systemic scleroderma. It may help doctors understand the condition better and improve how it’s assessed over time.
This trial tests new treatments for people with scleroderma-related lung disease. You may be eligible if you have systemic sclerosis with lung scarring, your symptoms started within the last 7 years, and you have not had certain prior treatments or transplants.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study looks at how systemic sclerosis (a condition causing skin thickening and organ issues) starts and gets worse. It may help researchers find better ways to treat or manage it.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
Hear when a new Systemic Scleroderma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.